Osmol Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Out of Business

  • Employees
  • 5

Employees

  • Latest Deal Type
  • Out of Business

Osmol General Information

Description

Developer of supportive care therapeutics designed for the prevention of chemotherapy-induced peripheral neuropathy and chemotherapy-induced cognitive impairment. The company's platform includes an intravenous drug candidate administered before chemotherapy that targets mechanisms associated with chemotherapy-related neuronal damage, enabling oncology patients to reduce the risk of treatment-related nerve and cognitive complications while maintaining chemotherapy treatment plans.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 33 Whitney Avenue, Floor 3
  • Suite 2B
  • New Haven, CT 06510
  • United States
+1 (203)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 33 Whitney Avenue, Floor 3
  • Suite 2B
  • New Haven, CT 06510
  • United States
+1 (203)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Osmol Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Out of Business 25-Oct-2026 Completed Out of Business
3. Later Stage VC (Series A1) 13-Apr-2022 Completed Clinical Trials - Phase 1
2. Secondary Transaction - Private 09-Mar-2017 $550K Completed Clinical Trials - Phase 1
1. Early Stage VC (Series A) 18-Jan-2017 $550K $550K Completed Clinical Trials - Phase 1
To view Osmol’s complete valuation and funding history, request access »

Osmol Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A-1
Series A
To view Osmol’s complete cap table history, request access »

Osmol Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Osmol FAQs

  • When was Osmol founded?

    Osmol was founded in 2016.

  • Where is Osmol headquartered?

    Osmol is headquartered in New Haven, CT.

  • What is the size of Osmol?

    Osmol has 5 total employees.

  • What industry is Osmol in?

    Osmol’s primary industry is Drug Discovery.

  • Is Osmol a private or public company?

    Osmol is a Private company.

  • What is Osmol’s current revenue?

    The current revenue for Osmol is .

  • How much funding has Osmol raised over time?

    Osmol has raised $8.05M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process